Absci and Caltech Join Forces, Bolstered by Major Grant, to Accelerate Affordable HIV Therapeutic Vaccine DevelopmentGlobeNewsWire • 08/10/23
Absci to Participate in the Morgan Stanley 2nd Annual Biotechnology AI SummitGlobeNewsWire • 06/15/23
Absci Evolves its Board of Directors with HealthTech Luminary Frans van Houten, Former CEO of PhilipsGlobeNewsWire • 06/06/23
Absci Corporation (ABSI) Reports Q1 Loss, Misses Revenue EstimatesZacks Investment Research • 05/15/23
Absci Reports Business Updates and First Quarter 2023 Financial and Operating ResultsGlobeNewsWire • 05/15/23
University of Oxford's Kennedy Institute of Rheumatology Partners with Absci to Accelerate AI-Driven ImmunotherapiesGlobeNewsWire • 05/11/23
Absci Corporation (ABSI) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 ReleaseZacks Investment Research • 05/03/23
Absci to Participate in the 22nd Annual Needham Virtual Healthcare ConferenceGlobeNewsWire • 04/06/23
Absci Reports Fourth Quarter and Full Year 2022 Financial and Operating ResultsGlobeNewsWire • 03/30/23
Absci to Participate in the B. Riley Securities' Life Sciences Tools Conference - Proteomics Setting the Blueprint for Innovative Drug CreationGlobeNewsWire • 03/23/23
Absci to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor ForumGlobeNewsWire • 03/07/23
St. John's Cancer Institute Partners with Absci to Expedite Development of Cancer TherapiesGlobeNewsWire • 02/09/23
Absci Deepens Scientific Advisory Board to Accelerate Generative AI Drug CreationGlobeNewsWire • 02/08/23
Absci Appoints Veteran Pharma Executive Andreas Busch, PhD as Chief Innovation OfficerGlobeNewsWire • 10/04/22
Absci to Participate at the Inaugural Gilmartin Group Emerging Growth Company ShowcaseGlobeNewsWire • 08/24/22